Viemed Healthcare Gross Profit

The latest gross profit for VMD is $170M as of June 2026. That compares with $140M in the prior-year period — up 23.6% year over year. That is below the Healthcare sector average of $65B. Investors often review this figure alongside Viemed Healthcare's historical trend and sector peers before judging valuation or financial health.

Over the past year, VMD's gross profit moved from $140M to $170M — a 23.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Viemed Healthcare's operating scale or balance-sheet position.

Against Healthcare companies, VMD currently prints $170M for gross profit, while the sector average sits near $65B. That is roughly 99.7% below the sector mean. Large gaps often invite a closer look at Viemed Healthcare's growth, margins, and balance sheet.

A gross profit figure of $170M for VMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $65B. Explore the charts below for those layers of context.

After noting VMD's gross profit ($170M), review year-over-year change from $140M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.